Where Does Alnylam Pharmaceuticals, Inc. (ALNY) Stock Fall in the Biotechnology Field After It Is Higher By 3.15% This Week?

Wednesday, November 30, 2022 02:30 PM | InvestorsObserver Analysts

Mentioned in this article

Where Does Alnylam Pharmaceuticals, Inc. (ALNY) Stock Fall in the Biotechnology Field After It Is Higher By 3.15% This Week?

Alnylam Pharmaceuticals, Inc. (ALNY) is around the top of the Biotechnology industry according to InvestorsObserver. ALNY received an overall rating of 65, which means that it scores higher than 65 percent of all stocks. Alnylam Pharmaceuticals, Inc. also achieved a score of 81 in the Biotechnology industry, putting it above 81 percent of Biotechnology stocks. Biotechnology is ranked 57 out of the 148 industries.

ALNY has an Overall Score of 65. Find out what this means to you and get the rest of the rankings on ALNY!

See Full ALNY Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 65 means the stock is more attractive than 65 percent of stocks. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Alnylam Pharmaceuticals, Inc. Stock Today?

Alnylam Pharmaceuticals, Inc. (ALNY) stock is trading at $216.00 as of 2:20 PM on Wednesday, Nov 30, a gain of $11.21, or 5.47% from the previous closing price of $204.79. The stock has traded between $205.19 and $217.55 so far today. Volume today is 707,564 compared to average volume of 779,082. Click Here to get the full Stock Report for Alnylam Pharmaceuticals, Inc. stock.